Reprieve Cardiovascular snaps up $7 mln
Reprieve Cardiovascular, a medical device company focused on patients suffering from acute decompensated heart failure, has secured $7 million in financing. The investors included Abiomed Inc. RenalGuard launched Reprieve Cardiovascular.
12 September 2018•1 min read
